RIPK-IN-4 is a potent and selective RIPK2 inhibitor with an IC50 of 3 nM, demonstrating excellent oral bioavailability. This compound is a valuable tool for investigating NOD signaling pathways in both cellular and animal models of inflammatory and autoimmune diseases.
Molekulargewicht:
392.45
CAS Nummer:
[2141969-56-2]
Formel:
C18H21FN4O3S
Target-Kategorie:
RIP kinase
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten